Senior Director, Team Lead, CDK4/6 Portfolio, US Breast Cancer

Pfizer•Collegeville, PA
•$230,900 - $384,800•Hybrid

About The Position

Pfizer Commercial Oncology is seeking a Senior Director, Team Lead to lead the US breast cancer CDK4/6 portfolio, encompassing IBRANCE and the planned successor atirmociclib. The role owns the IBRANCE P&L and atirmociclib pre-launch investment plan, including forecasting, operating expenses, resource allocation, revenue and expense trade-offs associated with loss of exclusivity, and deliberate redeployment of released resources to portfolio priorities. The position reports to the VP, US Breast Cancer Franchise Lead and leads 6–8 HCP and patient marketers at Director and Senior Manager levels. The leader will set a multi-year strategy for the transition from IBRANCE to atirmociclib: maximizing IBRANCE value through the PATINA launch, heritage campaign, IRA changes and LOE, while building atirmociclib’s market, evidence base, launch readiness and organization. This includes strategic and tactical leadership across HCP, account, patient, advocacy, market access, pricing, trade, sales, analytics and cross-functional stakeholder engagement. The role is a member of the BC franchise leadership team and the broader Oncology Business extended leadership team.

Requirements

  • Bachelor’s degree and 12 or more years of pharmaceutical industry experience, or a Master’s degree and 10 or more years of pharmaceutical industry experience.
  • Pharmaceutical or biotechnology commercial experience, including US brand management and P&L accountability.
  • Deep understanding of US market dynamics, including specialty channels, oncology organized customers and payers.
  • Demonstrated use of AI and advanced analytics to improve customer insight, targeting, forecasting and investment decisions.
  • Track record of championing innovative solutions that change how a team works.
  • Demonstrated success developing, executing and measuring complex marketing programs.
  • Proven ability to identify customer needs and translate insights into meaningful strategies and tactics.
  • At least 5 years of direct or matrix management or coaching of marketing colleagues at Manager through Director levels.
  • Commitment to team engagement, a positive team culture and developing people.
  • Ability to collaborate across a wide range of cross-functional areas to improve business performance and find a path forward.
  • Strong analytical skills; detail- and action-oriented, creative, flexible and self-motivated.
  • Excellent verbal and written communication skills for varied audiences, including senior executives.
  • Ability to synthesize and analyze complex data, understand trends and perform mathematical calculations.
  • Ability to work on a computer for extended periods using common applications such as Outlook, Excel and PowerPoint.
  • Comfort working in a fast-paced environment and making complex decisions quickly.
  • Ability to travel domestically and internationally as needed; travel may be up to 25%.
  • Permanent work authorization in the United States is required.

Nice To Haves

  • Oncology marketing experience.
  • Experience managing a brand through loss of exclusivity.
  • Experience leading a US oncology or specialty product launch, from pre-launch market shaping through first-line commercialization.
  • Experience designing, piloting or scaling new go-to-market models, such as omnichannel or AI-enabled customer engagement, hybrid field/digital coverage or account-based approaches, and applying them through a brand lifecycle transition.
  • Experience leading patient marketing, including DTC/DTP strategy, patient support and adherence programs, and advocacy engagement, and integrating patient and HCP strategies into one customer plan.

Responsibilities

  • Define and execute IBRANCE strategy through loss of exclusivity, including identifying incremental growth opportunities and leading LOE scenarios, customer and account communications, partnerships, patient marketing and generic-entry readiness.
  • Own IBRANCE P&L management, marketing performance and investment levels; optimize return on investment through trade-offs and redeploy savings to franchise priorities.
  • Set a multi-year atirmociclib strategy and launch-readiness plan for frontline metastatic breast cancer and early breast cancer indications.
  • Develop atirmociclib pricing, contracting, channel, distribution and gross-to-net strategies with Market Access, Pricing and Trade.
  • Lead US HCP and account strategy for atirmociclib, including positioning, segmentation, target customers and launch planning.
  • Shape the first-line market before approval through disease-state education and pre-launch engagement with Medical Affairs and Clinical Development.
  • Define launch-readiness milestones, evidence needs and the investment case in partnership with Global, Market Access, Commercial Insights and Sales.
  • Measure the impact of marketing initiatives using advanced analytics, apply learnings and continuously improve against brand objectives.
  • Ensure marketing materials are compelling, compliant and appropriate across channels, including AI-enabled and omnichannel touchpoints.
  • Identify customer insights with Medical, market analytics, AI/data science, field force and prescribers, and translate them into actionable strategies.
  • Develop an integrated patient strategy and partner with enterprise patient-support functions to create an end-to-end patient experience that removes treatment barriers.
  • Lead patient marketers responsible for direct-to-patient marketing, patient support and adherence programs for IBRANCE and atirmociclib.
  • Connect patient journeys by building an operating model, metrics and feedback loops linking field sales and marketing execution to shared commercial outcomes.
  • Define how customers, accounts and field effort transition from IBRANCE to atirmociclib, including segments, messages and timing.
  • Align with Breast Cancer Sales and Key Account Director leadership on sales meetings, customer-facing colleague feedback, CDK class leadership and changing field priorities.
  • Lead customer insight planning with analytics and customer-facing colleagues, and use insights to adapt strategy and anticipate HCP choices during the portfolio transition.
  • Coordinate with other franchise asset leads so patient journeys and messages are connected and consistent.
  • Lead, develop, engage and coach Director- and Senior Manager-level marketers; plan roles, development and succession as portfolio needs change.
  • Foster a positive team culture and collaboration across the broader US Breast Cancer marketing team.
  • Contribute as a member of the BC franchise leadership team and the broader Oncology Business extended leadership team.

Benefits

  • 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution.
  • Paid vacation, holiday and personal days.
  • Paid caregiver/parental and medical leave.
  • Medical, prescription drug, dental and vision coverage.
  • Eligible to participate in Pfizer’s Global Performance Plan, with a bonus target of 25% of base salary.
  • Eligible to participate in a share-based long-term incentive program.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service